Stockreport

Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials Grant

BIOPHARMX CORP  (BPMX) 
NASDAQ:AMEX Investor Relations: biopharmx.com
PDF WOODCLIFF LAKE, N.J., April 6, 2020 /PRNewswire/ -- Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and comm [Read more]